Schrodinger, Inc. (SDGR)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Schrodinger, Inc. chart...

About the Company

We do not have any company description for Schrodinger, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

450

Exchange

Nasdaq

$216M

Total Revenue

450

Employees

$2B

Market Capitalization

70.54

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SDGR News

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

7d ago, source:

Schrödinger today reported that on April 15, 2024, the company granted (i) non-statutory stock options and (ii) restricted ...

Schrodinger and Takeda scientists discover new 3CLpro inhibitors

15d ago, source: BioWorld

Researchers at Schrodinger Inc. and Takeda Pharmaceutical Co. Ltd. have described 3C-like proteinase (3CLpro; Mpro; nsp5) inhibitors reported to be useful for the treatment of coronavirus acute ...

5 Healthcare Stocks to Buy for 2024

23d ago, source:

Shares of biopharmaceutical firm Nuvectis (NASDAQ: NVCT) soared 200% after going public at $5 per share in 2022. Chris ...

Moderna and OpenAI in pact to fast-track drug development

on MSN ago, source:

Moderna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines.

6 Under-the-Radar AI Stocks That Analysts Expect to Rally

1y ago, source:

Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

7 Growth Stocks to Buy Now: Q2 Edition

on MSN ago, source:

Investing in growth stocks can deliver outsized gains, but investors have to stick with these stocks during volatile ...

Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer

2d ago, source:

Congruence Therapeutics, a leading computationally-driven biotechnology company developing a pipeline of novel small molecules for diseases with significant unmet medical need, announced today the ...

Colorado companies begin groundwork for future moon economy

11d ago, source:

The Apollo missions to bring mankind to the moon for the first time more than 50 years ago is a small step in comparison to ...

9 Best Biotech ETFs for 2024

6d ago, source: GOBankingRates on MSN

Biotechnology uses living organisms to develop new medicines and technologies that benefit both environmental and social ...

Materials informatics Market Size to Worth USD 1,572.93 Million by 2033

17h ago, source:

The global materials informatics market size is calculated at USD 252.9 million in 2024 and is estimated to be worth around USD 1,572.93 million by 2033, expanding at a notable CAGR of 23.05% from ...

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

1d ago, source: Business Insider

-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET Phase 2 ...

PSG And Barcelona Turned A Champions League Feast Into A Soggy Appetizer

7d ago, source: defector

If you were to look only at the raw facts of the matter, you might think Tuesday’s Champions League quarterfinal clash ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...